emtricitabine
FDA Approves Symtuza, the First Complete Darunavir-Based, Single-Tablet Regimen for HIV
The FDA recently approved Janssen's Symtuza, the first complete darunavir-based, single-tablet regimen for the ...
JULY 19, 2018
New Data Support TAF Switch in HIV
A subanalysis of the phase 3 Study 109 supports switching HIV patients who are virologically suppressed from a ...
OCTOBER 18, 2017
Once-Daily, Single-Tablet Regimen Suppressed HIV
AIDS Society Conference on HIV: A once-daily, single-tablet regimen (STR) containing Prezista, Tybost, Emtriva and ...
AUGUST 1, 2017
Load more